Core Laboratories (CLB) anticipates revenues and operating income in the range of $128-$132 million and $15.2-$17.5 million, respectively, with earnings in the band of 21-25 cents per share for Q3 202
The headline numbers for Core Laboratories (CLB) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street

Core Laboratories (CLB) Tops Q2 Earnings Estimates

07:56pm, Wednesday, 26'th Jul 2023
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.12 per share a year ago.
HOUSTON , June 27, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will broadcast its second quarter 2023 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m.
Business is improving for Core Laboratories Inc. at a very modest incremental pace. The company lacks a moat or a near-term catalyst.
Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.
Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript.
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.08 per share a year ago.
Eight members of OPEC+ decided to cut their oil production by a combined 1.16 million barrels per day. The move follows a 2 million barrel per day OPEC+ cut back in October.
Halliburton (HAL), Core Labs (CLB) and Schlumberger Ltd. (SLB) are likely to have been impacted by poor sentiment, rising costs, and weak prices in Q1.
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
A big inventory build in the U.S. and fears of higher interest rates caused these oil-related stocks to fall.
Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
Core Laboratories N.V. (NYSE:CLB ) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Larry Bruno - Chairman & CEO Chris Hill - CFO Gwen Gresham - SVP & Head, IR Confere
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.26% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE